Join the Oncology Voice Network. Join for Free
Surround to Succeed: Building a Motivational Network
MSL recruiter motivational network career satisfaction industry challenges proactive networking

Surround to Succeed: Building a Motivational Network


Share This Article


Summary

This week’s guest is Sarah Snyder, MSL Recruiter with The Carolan Group who discusses the importance of surrounding yourself with a motivational network.

Key Points

  • Surrounding yourself with the right people, including those who challenge and support you, can significantly impact your career satisfaction and success.
  • Job seekers should seek out individuals who understand the industry's challenges and can provide encouragement and realistic guidance through setbacks.
  • MSLs, particularly those feeling isolated in field-based roles, should proactively network with peers and mentors, both in-person and online, to stay motivated and connected.

Click for Source
MSL recruiter, motivational network, career satisfaction, industry challenges, proactive networking

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
How to Leverage YOUR Unique Skills for Career Advantage
Partner Avatar MSL Talk: Tom Caravela, Hahn-Ey Lee

How to Leverage YOUR Unique Skills for Career Advantage

Podcast
Diagnostic MSL - More Similar Than Different E199 • Apr 2, 2024 • 23 mins
Partner Avatar MSL Talk: Tom Caravela, Keith Fairall

Diagnostic MSL - More Similar Than Different E199 • Apr 2, 2024 • 23 mins

Article
Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology
OVN Avatar Sonoko Kawakatsu, René Bruno, Matts Kågedal, Chunze Li, Sandhya Girish, Amita Joshi, Benjamin Wu

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Article
Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals
OVN Avatar R. Kurzrock, L.A. Gurski, R.W. Carlson, D.S. Ettinger, S.M. Horwitz, S.K. Kumar, L. Million, M. von Mehren, A.B. Benson III

Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals

Article
EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies
OVN Avatar Barbara Kiesewetter , Nathan I Cherny, Nicolas Boissel, Francesco Cerisoli, Urania Dafni, Elisabeth G E de Vries, Paolo Ghia, Nicola Gökbuget, Verónica González-Calle, Brian Huntly, Ulrich Jäger, Nicola Jane Latino, Jean-Yves Douillard, Luca Malcovati, Ma

EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies

Article
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions
OVN Avatar Charles L. Bennett , Sumimasa Nagai , Andrew C. Bennett , Shamia Hoque , Chadi Nabhan , Martin W. Schoen , William J. Hrushesky , Stefano Luminari , Paul Ray , Paul R. Yarnold , Bart Witherspoon , Josh Riente , Laura Bobolts , John Brusk , Rebecca Tombles

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions

Explore OVN